论文部分内容阅读
全身性硬皮症(PSS)不仅在皮肤,而且在内脏诸脏器上亦发生病变,其病变对预后影响很大。Casas 等以1987年外用5-FU 治疗足底纤维硬化患者,见症状减轻和5-FU 治疗肺癌中的 PSS 病例,皮肤硬化亦见减轻为依据,在12例 PSS 中应用了5-FU 静滴,发现皮肤及肺等内脏病变、自觉及他觉症状均见改善。不久前,作者对合并桥本氏病,伴有肺纤维症的全身性硬皮病的1例应用5-FU 静滴也取得了明显疗效,故以本例为中心,将5-FU 静滴治疗全身硬皮病方法简述如下。
Systemic scleroderma (PSS) not only in the skin, but also in visceral organs also occur lesions, the prognosis of the disease a great influence. Casas and other topical fibrosis patients treated with 5-FU in 1987, see the reduction of symptoms and 5-FU treatment of lung cancer in patients with PSS, also see reduction of skin sclerosis, 12 cases of PSS application of 5-FU infusion , Found that visceral lesions such as the skin and lungs, consciously and he felt symptoms improved. Not long ago, the authors of the merger of Hashimoto’s disease, systemic fibrosis associated with systemic scleroderma in 1 case of application of 5-FU intravenous infusion also achieved significant effect, so in this case as the center, the 5-FU intravenous infusion The treatment of systemic scleroderma method is summarized as follows.